Updated
Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C funding round. The company plans to use the money to move its drug candidates into clinical trials. The round signals strong investor confidence in AI-driven approaches to drug discovery.
Sources:TechCrunch